First Time Loading...

Vivos Therapeutics Inc
NASDAQ:VVOS

Watchlist Manager
Vivos Therapeutics Inc Logo
Vivos Therapeutics Inc
NASDAQ:VVOS
Watchlist
Price: 2.59 USD 5.28% Market Closed
Updated: Apr 29, 2024

Vivos Therapeutics Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vivos Therapeutics Inc
Operating Income Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Vivos Therapeutics Inc
NASDAQ:VVOS
Operating Income
-$17.3m
CAGR 3-Years
-13%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Operating Income
$1.6B
CAGR 3-Years
-2%
CAGR 5-Years
1%
CAGR 10-Years
-1%
Quest Diagnostics Inc
NYSE:DGX
Operating Income
$1.3B
CAGR 3-Years
-20%
CAGR 5-Years
2%
CAGR 10-Years
2%
CVS Health Corp
NYSE:CVS
Operating Income
$15.1B
CAGR 3-Years
3%
CAGR 5-Years
8%
CAGR 10-Years
7%
Cigna Corp
NYSE:CI
Operating Income
$9B
CAGR 3-Years
2%
CAGR 5-Years
14%
CAGR 10-Years
15%
Laboratory Corporation of America Holdings
NYSE:LH
Operating Income
$1.1B
CAGR 3-Years
-34%
CAGR 5-Years
-5%
CAGR 10-Years
2%

See Also

What is Vivos Therapeutics Inc's Operating Income?
Operating Income
-17.3m USD

Based on the financial report for Dec 31, 2023, Vivos Therapeutics Inc's Operating Income amounts to -17.3m USD.

What is Vivos Therapeutics Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-16%

Over the last year, the Operating Income growth was 31%. The average annual Operating Income growth rates for Vivos Therapeutics Inc have been -13% over the past three years , -16% over the past five years .